DiagnAll — AI-powered cardiac diagnostics and heart monitoring solutions.
DiagnAll provides cutting-edge artificial intelligence powered cardiac diagnostic solutions for continuous heart monitoring, ECG analysis, and real-time cardiac anomaly detection. Our medical-grade wearable technology serves healthcare professionals, athletes, and patients with advanced heart health insights and arrhythmia screening capabilities.
cardiac diagnostics, heart monitoring, ECG analysis, AI cardiology, wearable heart monitor, cardiac screening, arrhythmia detection, heart health technology, medical devices, continuous cardiac monitoring, sports cardiology, preventive cardiology
Cardiovascular disease remains the world's leading cause of death. But the heart often shows signals before a crisis becomes visible. We are building to help listen earlier, longer, and more clearly.
DiagnAll brings together biomedical engineering, artificial intelligence, and clinical thinking to make long-term heart monitoring easier to understand and easier to act on. Our goal is not to replace clinicians, but to support them with clearer signals, better context, and more continuous data.
DiagnAll is a health-tech team building AI-assisted tools for continuous cardiac monitoring. We combine biomedical engineering, ECG signal analysis, and product design to help transform heart data into useful insight for patients and clinicians.
Heart-related risk is often difficult to capture in a single appointment or short recording. More continuous monitoring can help reveal patterns that might otherwise be missed between clinical visits.
We focus on discreet wearable sensing, careful AI analysis, and clinically responsible workflows. Cardion is designed to support awareness and review, not to create noise, panic, or unsupported medical claims.
Our product, Cardion, is the first and only AI-powered ECG patch designed to identify myocardial infarction risk before emergency escalation. Its end-to-end pipeline analyzes a 60-second ECG recording and generates a cardiac risk score across a 1–168 hour prediction window, supporting earlier clinical review for high-risk cardiac patients.
Cardion replaces bulky wires and traditional monitoring equipment with a compact, non-invasive patch that sticks comfortably to the chest for everyday wear.
With just one minute of ECG data, our AI/ML model can uncover hidden warning patterns and estimate heart attack risk up to one week ahead.
If elevated risk is detected, the app notifies the patient and connects the result with their cardiologist for review.
We are a multidisciplinary team working across engineering, AI, biomedical signals, product development, and healthcare communication. What connects us is a simple belief: heart monitoring should be more continuous, more understandable, and more human.
Scroll to explore our progress from concept to validation.
Milestone 01
More than 100 stakeholder interviews and 410+ survey responses helped validate the unmet need, define our high-risk patient segment and shape Cardion's clinical and product direction.
Milestone 02
We developed and tested the first functional Cardion prototype, combining wearable ECG acquisition, embedded electronics and wireless data transmission.
Milestone 03
We progressed from 12-lead clinical ECG data to 3-lead and ultimately 1-lead myocardial infarction risk prediction, evaluating 10,640 recordings from 8,573 patients and achieving 85.9% AUROC across a 1–168-hour risk window.
Milestone 04
We built a complete pipeline that captures signals from Cardion's hardware, performs signal-quality checks and preprocessing, and generates a myocardial infarction risk estimate in real time.
Cardion is still under development, but our work is already moving from research and proof of concept toward product design, validation planning, and clinical collaboration.
May 2025
July 2025
November 2025
December 2025
January 2026
🚧 Under Construction
This feature is coming soon!
